4/2
08:30 am
bdrx
Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies
High
Report
Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies
3/31
08:00 am
bdrx
Tanner Pharma Group and Biodexa Launch Global Early Access Program for FAP Patients
Low
Report
Tanner Pharma Group and Biodexa Launch Global Early Access Program for FAP Patients
3/30
10:41 am
bdrx
BDRX: Initiating Coverage of Biodexa Pharmaceuticals; A Deep Value Oncology Platform Built Around Two High-Conviction Areas [Yahoo! Finance]
Medium
Report
BDRX: Initiating Coverage of Biodexa Pharmaceuticals; A Deep Value Oncology Platform Built Around Two High-Conviction Areas [Yahoo! Finance]
3/30
01:04 am
bdrx
Medium
Report
3/27
07:15 pm
bdrx
Preliminary Results for the Year Ended 31 December 2025 [Yahoo! Finance]
Medium
Report
Preliminary Results for the Year Ended 31 December 2025 [Yahoo! Finance]
3/27
05:00 pm
bdrx
Preliminary Results for the Year Ended 31 December 2025
High
Report
Preliminary Results for the Year Ended 31 December 2025
3/23
09:14 am
bdrx
Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group [Yahoo! Finance]
Medium
Report
Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group [Yahoo! Finance]
3/23
08:30 am
bdrx
Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group
Medium
Report
Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group
3/22
01:04 am
bdrx
Low
Report
3/18
05:12 pm
bdrx
Biodexa Pharmaceuticals announces ADR ratio change [Seeking Alpha]
Medium
Report
Biodexa Pharmaceuticals announces ADR ratio change [Seeking Alpha]
3/18
05:10 pm
bdrx
ADR Ratio Change [Yahoo! Finance]
High
Report
ADR Ratio Change [Yahoo! Finance]
3/18
05:00 pm
bdrx
ADR Ratio Change
High
Report
ADR Ratio Change
3/9
08:51 am
bdrx
Biodexa Announces Support for Life's a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients [Yahoo! Finance]
Medium
Report
Biodexa Announces Support for Life's a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients [Yahoo! Finance]
3/9
08:30 am
bdrx
Biodexa Announces Support for Life’s a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients
Medium
Report
Biodexa Announces Support for Life’s a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients
2/22
02:02 am
bdrx
Biodexa Pharmaceuticals (NASDAQ:BDRX) was upgraded by analysts at
Wall S
Low
Report
Biodexa Pharmaceuticals (NASDAQ:BDRX) was upgraded by analysts at
Wall S
2/4
08:30 am
bdrx
Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST
High
Report
Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST
1/24
12:30 am
bdrx
Biodexa Pharmaceuticals (NASDAQ:BDRX) was upgraded by analysts at
Wall S
Low
Report
Biodexa Pharmaceuticals (NASDAQ:BDRX) was upgraded by analysts at
Wall S